50
Nanopharmacology and Nanomedicine Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D. Director and Professor KLE College of Pharmacy, NIPANI-591 237, Karnataka, India. E-mail: [email protected] Cell No: 0091 9742431000 1 Suvarna JNMC National Seminar, Belgaum. 15 February 2013

Nanopharmacology and Nanomedicine

  • Upload
    aysha

  • View
    269

  • Download
    3

Embed Size (px)

DESCRIPTION

Nanopharmacology and Nanomedicine. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D. Director and Professor KLE College of Pharmacy, NIPANI- 591 237 , Karnataka, India. E-mail: [email protected] Cell No: 0091 9742431000. Nanotechnology map. Nanoscience. - PowerPoint PPT Presentation

Citation preview

Page 1: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 1

Nanopharmacology and

Nanomedicine

Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D.

Director and ProfessorKLE College of Pharmacy,

NIPANI-591 237, Karnataka, India.E-mail: [email protected]

Cell No: 0091 9742431000

15 February 2013

Page 2: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 2

Nanotechnology map

15 February 2013

Page 3: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 3

Nanoscience• Nanoscale has different definitions in different

scientific fields such as 1-100 nanometers in physics and chemistry, 0.1-100 nm in some early monograghs and 1-1000 nm in biomedicine literatures.

• The bottom up assemble with atoms one by one

• 100 nm (or below) particles at bone marrow,

• 100-200 nm particles at reticular epithelial systems.

15 February 2013

Page 4: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 4

Nanopharmacology• Nanopharmacology, a new branch of

pharmacology is gradually emerging with the application of nanoscience and nanotechnology in the field of nanomedicine.

• The interactions between traditional drugs and physiological systems at nanoscle level.

15 February 2013

Page 5: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 5

Nanopharmacology Drug design and drug delivery to

selected targets to improve pharmacodynamics and kinetic profiles toward safer and effective treatment is known as nanopharmacology.

15 February 2013

Page 6: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 6

Categorized Nanopharmacology

• Defining targets

• Development of drugs and carrier systems

• Studying target–drug interactions

• Monitoring the target–drug interaction outcomes

15 February 2013

Page 7: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 7

Defining targets

15 February 2013

Page 8: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 8

Development of drugs and carrier systems

15 February 2013

Page 9: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 9

Studying target–drug interactions

15 February 2013

• Pharmacokinetic interactions– Absorption– Distribution– Biotransformation– Excretion

• Pharmacodynamic interactions– Receptor interaction– Receptor sensitivity– Neurotransmitter release/Drug transportation– Electrolyte balance

• Pharmaceutical interactions

Page 10: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 10

Studying target–drug interactions

15 February 2013

Usually, the binding sites of macromolecules are more hydrophobic in nature than the surface, and so this enhances the effect of an ionic interaction.

The drop off in ionic bonding strength with separation is less than in other intermolecular interactions, so if an ionic interaction is possible, it is likely to be the most important initial interaction as the drug enters the binding site.

Page 11: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 11

Quantitative systems pharmacology

15 February 2013

Page 12: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 12

Monitoring the target–drug interaction outcomes

1) Loss of therapeutic effect2) Toxicity3) Unexpected increase in pharmacological

activity4) Beneficial effects e.g additive &

potentiating (intended) or antagonism (unintended).

5) Chemical or physical interaction e.g I.V incompatibility in fluid or syringes

mixture 15 February 2013

Page 13: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 13

Nanopharmacology features

1. Using nanoscale tools, such as scanning probe microscopy.

2. Studying particulate drugs, especially the nanoparticulate drugs.

3. Studying the influences of the nanoparticulate properties of nano drug carriers on the therapeutic effects of drugs that they carry.

4. Nanopharmacology theories will provide instructions for the bottom up assemble of nanodrugs with atoms one by one.

15 February 2013

Page 14: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 14

Nanopharmacology Target• Slow release nanopharmacology

• Controlled release nanopharmacology

• Bio barrier penetration nanopharmacology

15 February 2013

Page 15: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 15

Slow release nanopharmacology

• The slow-release nanopharmacology studies the question on how to realize the slow release and the influences of slow release on the drug metabolisms and the therapeutic effects.

15 February 2013

Page 16: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 16

Slow release nanopharmacology

15 February 2013

Page 17: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 17

Controlled release nanopharmacology

• The controlled-release nanopharmacology studies how to realize the smart release of the drugs according to the therapeutic needs in the cellular and tissue microenvironments.

15 February 2013

Page 18: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 18

Bio barrier penetration nanopharmacology

• Bio-barrier-penetration nanopharmacology studies the capabilities of nanodrugs to passing through bio-barriers.

• Blood-brain barrier• Air-blood barrier

• To realize the treatment of some focal diseases where the traditional drugs can’t arrive because their incapability of penetrate biobarriers.

15 February 2013

Page 19: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 19

Transport of molecules across the BBB

15 February 2013

Page 20: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 20

Air-blood barrier

15 February 2013

Page 21: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 21

The perfect drug!

Reality• All drugs have side effects but new drugs aim to

provide beneficial effects with minimal side effects

How is this achieved?

1. Identify new molecules2. Modify structure of know molecules

• Test in biological tissue or whole body

15 February 2013

Page 22: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 22

Nanotechnology – based drug delivery Systems

15 February 2013

Page 23: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 23

Nanomedicine

15 February 2013

Page 24: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 24

Definition of Nanomedicine

• Nanomedicine is the one of the most valuable  medical application of nanotechnology as the name specifies naomedicine involves the use of nano particles in the surgical and medical treatement of pateints.

OR

• We can say nanomedicine is the nanotechnology application which is used for engineering or binding molecular or atomic machines for the treatment of diseases in living organisms.

15 February 2013

Page 25: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 25

Nanomedicine– Nanomedicine is nanotechnology used for

the treatment, diagnosis, monitoring and control of biological systems

– Nanomedicine includes the delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents using nanoparticles to cancer and other cells

– Nanomedicine includes nanomaterial for bone, cartilage, vascular, bladder and neural applications

15 February 2013

Page 26: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 26

Background• Nanomedicine is the monitoring, repair,

construction, and control of human biological systems at the molecular level using engineered nanodevices and nanostructures.

• Nanomedicine, including nanodiagnostics, nanotherapeutics, and the development of nanomedical devices.

15 February 2013

Page 27: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 27

How nanomedicine works?

• Nanomedicine works at a molecular or atomic  scale.

• The most advanced form of nanomedicine uses the nanorobots and nanoinstruments as surgeons.

• Nanomedicine repair damaged cells or get into the cells and replace or assist damaged intracellular structures at individual stage.

15 February 2013

Page 28: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 28

Goals of Nanomedicine

15 February 2013

• End goal of nanomedicine is improved diagnostics, treatment and prevention of disease

Page 29: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 29

Goals of Nanomedicine

15 February 2013

• Ultimate goal is to integrate detection, diagnostics, treatment and prevention of disease into a personalized single platform

Page 30: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 30

Recent and future breakthroughs in medicine

15 February 2013

• Nanotechnology holds key to a number of recent and future breakthroughs in medicine

Page 31: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 31

Cancer Treatments

15 February 2013

• Because of their small size, nanoparticles can pass through interstitial spaces between necrotic and quiescent cells.

• Tumor cells typically have larger interstitial spaces than healthy cells

• Particles collect in center bringing therapeutics to kill the tumor from inside out.

Page 32: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 32

Nanoparticles as Sensors and Therapeutics

15 February 2013

• Glutathione (GSH) provides a selective and tunable release mechanism

• Once inside cells, fluorophores and drugs selectively dissociate

Page 33: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 33

Nanoparticle Success

15 February 2013

• Both cationic and anionic particles penetrate and accumulate in tumors.

• However, only cationic particles diffuse fully throughout the tumor.

Page 34: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 34

Types of contrast agents used for MRI

15 February 2013

Page 35: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 35

Contrast agents used for MRI

15 February 2013

Page 36: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 36

Advantages and applications

• Diagnosis using nanomedicine• Nervous system tracking • Drugs dispersion• Artificial antibodies.

• One of the biggest advantage of naonoemdicne is that it can transform common medical procedures into  faster one with 90 percent accuracy rate.

15 February 2013

Page 37: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 37

Diagnosis using nanomedicine

• Diagnostic nano-apparatus could be attached to keep check of the internal chemistry of the body.

• Mobile nanorobots, with wireless transmitters, could easily circulate in the blood and lymph systems and send out alerts when chemical imbalances appear within the blood.  

15 February 2013

Page 38: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 38

Drugs and contrast agents

15 February 2013

Page 39: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 39

Detection of Cancer

15 February 2013

Breast Cancer Cells Healthy Cells

• On the left, cancer cells fluorescence.• On the right, healthy cells show minimal

fluorescence.

Page 40: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 40

Nervous system tracking • Nanomedicine has also helped doctors to

better understand the phenomenal changes in the human nervous systems.

• Fixed nanomachines could be inserted in the nervous system of the human body to monitor pulse rate, brain activity, and other important functions.

15 February 2013

Page 41: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 41

Drugs dispersion• Live saving drugs are one of the important

ingredients in the latest medicines but its unusual and excess usage could cause death.

• Nanomedicine also has successful applications for the reduction of extra drugs from human body.

• Implantation of nanomedicine devices could disperse drugs or hormones as required in people with chronic imbalance or deficiency states.

15 February 2013

Page 42: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 42

Nanomedicine platform for targeted drug delivery

15 February 2013

Page 43: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 43

Artificial antibodies• Nanomedicine was the first to conceptualize

the artificial red and white blood cells and later on it successfully showed the positive results.

• Cancer patients are now treated by injecting artificial red blood cells to balance the human body blood level.

• Artificial antibodies, white & red blood cells and antiviral nanorobots could be considered as successful applications of nanomedicine.15 February 2013

Page 44: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 44

Nanorobots• Imagine going to the doctor to get

treatment for a persistent fever. • Instead of giving a pill or a shot, the doctor

refers you to a special medical team which implants a tiny robot into your bloodstream.

• The robot detects the cause of your fever, travels to the appropriate system and provides a dose of medication directly to the infected area.

• To treat everything from hemophilia to cancer.

15 February 2013

Page 45: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 45

Nanorobots• A viable nanorobot has to be small enough

to navigate through the human circulatory system, an incredibly complex network of veins and arteries.

• The nanorobot must also have the capacity to carry medication or miniature tools.

15 February 2013

Page 46: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 46

Nanorobot

15 February 2013

Page 47: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 47

Advantages of Nanoscale devices in Medicine

• Devices smaller than 50 nm can easily enter most cells

• Devices smaller than 20 nm can transit out of blood vessels

• Devices are capable of holding thousands of small molecules• Contrast Agents• Drugs

15 February 2013

Page 48: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 48

Major Areas of Development of Nanomedicine

• Prevention and control• Early detection • Imaging diagnostics• Multifunctional Therapeutics

15 February 2013

Page 49: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 49

Medicines research

15 February 2013

Page 50: Nanopharmacology and  Nanomedicine

Suvarna JNMC National Seminar, Belgaum. 50

Thank Youe-mail: [email protected]

Cell No: 0091 9742431000

15 February 2013